Frazier Life Sciences Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.1M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $7.81M | Hold |
|
|||||
|
2024
Q4 | $8.63M | Hold |
|
|||||
|
2024
Q3 | $7.23M | Hold |
|
|||||
|
2024
Q2 | $7.64M | Hold |
|
|||||
|
2024
Q1 | $8.7M | Sell |
|
|||||
|
2023
Q4 | $22.9M | Buy |
|
|||||
|
2023
Q3 | $13.1M | Sell |
|
|||||
|
2023
Q2 | $20.5M | Hold |
|
|||||
|
2023
Q1 | $16.1M | Hold |
|
|||||
|
2022
Q4 | $13.6M | Hold |
|
|||||
|
2022
Q3 | $14M | Buy |
|